# Biogen

Organization · id `cardio:org-biogen` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Biogen>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 8 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Biogen
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease (`cardio:ct-nct01053936`)
- Sponsors: Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes (`cardio:ct-nct01351675`)
- Sponsors: Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke (`cardio:ct-nct01955707`)
- Sponsors: Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT (`cardio:ct-nct02036970`)
- Sponsors: Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST (`cardio:ct-nct02657356`)
- Sponsors: Safety and Efficacy of Intravenous Natalizumab in Acute Ischemic Stroke (`cardio:ct-nct02730455`)
- Sponsors: Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER (`cardio:ct-nct03068130`)
- Sponsors: An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) (`cardio:ct-nct03749447`)

## Provenance

Content hash: 6c37fabf8aef9bbd78adbafdb1f0537a85dd455ddd0e3b431f044f4545b47491
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
